About ▼ Careers Internship MedBlog Contact us

LOGIN REGISTER

Medindia » News » Drug News » For the First Time, Alzheimer's Drug Will be Funded in NZ

For the First Time, Alzheimer's Drug Will be Funded in NZ

Drug-buying agency Pharmac has announced that for the first time a medicine specifically targetting Alzheimer's Disease and dementia will be funded in New Zealand.

For the First Time, Alzheimer`s Drug Will be Funded in NZ

Drug-buying agency Pharmac has announced that for the first time a medicine specifically targetting Alzheimer's Disease and dementia will be funded in New Zealand.

Pharmac revealed that it plans to buy the Donepezil Rex brand of medicines after the drug is registered with medicines safety regulator Medsafe. This decision was made because evidence indicates drugs belonging to the class of acetylchlorinesterase inhibitors may slow the progression of Alzheimer's in some patients.

Alzheimer’s disease - Causes, Symptoms, Diagnosis, Stages, Types, Prevention, Prognosis & Treatment

Alzheimer’s disease - Causes, Symptoms, Diagnosis, Stages, Types, Prevention, Prognosis & Treatment
Alzheimer's disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.

Donepizil will become available without restriction to an estimated 15,000 people in the country after Pharmac managed to reduce the $32 million price tag on the drug by 95%.

Source-Medindia
RAS

About Schizophrenia

About Schizophrenia
Schizophrenia is a mental disorder characterized by symptoms of thought, behavior and social problems.

Dyslexia - Causes, Symptoms, Diagnosis, Treatment

Dyslexia - Causes, Symptoms, Diagnosis, Treatment
Dyslexia is a reading disability that occurs when the brain does not properly recognize and process certain symbols.

Recommended Readings

Genetics of Alzheimer´s disease

Genetics of Alzheimer´s disease

There are numerous genes that have been discovered that are associated with Alzheimer’s disease and indicate increased risk, aiding genetic counseling and better care.

Creutzfeldt-Jakob Disease

Creutzfeldt-Jakob Disease

Creutzfeldt-Jakob disease (CJD) is a rare form of degenerative brain disorder, or brain damage that leads to a rapid decrease of mental function and movement.

Mini-Mental Scale (Cognitive Function Test)

Mini-Mental Scale (Cognitive Function Test)

The MMSE (Mini-Mental State Examination) is a standardized screening test that is used for easy and fast assessment of the various aspects of cognition in a person.

Diet and Alzheimer´s Disease

Diet and Alzheimer´s Disease

Alzheimer''s begins with forgetfulness, but over time affects speech and coordination along with drastic behavioral changes. The right diet may lower your risk by 40%. So isn''t a diet change worth it?

Drug Toxicity

Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a drug, reaction to a drug or drug abuse.

Latest Drug News

Tecovirimat Safe but Ineffective for Resolving Mpox Symptoms

Tecovirimat Safe but Ineffective for Resolving Mpox Symptoms

Study finds tecovirimat safe but ineffective in reducing mpox lesions or pain.

L-Arginine as a Treatment for Spinocerebellar Ataxia: A Clinical Trial Overview

L-Arginine as a Treatment for Spinocerebellar Ataxia: A Clinical Trial Overview

A Phase 2 trial investigates the potential of L-arginine as a treatment for Spinocerebellar Ataxia Type 6, showing mild improvements and highlighting the need for further studies.

Weight Loss Drug Tirzepatide Demonstrates Diabetes Prevention

Weight Loss Drug Tirzepatide Demonstrates Diabetes Prevention

Tirzepatide, a weight loss drug, shows promise in preventing diabetes by improving insulin sensitivity and aiding in weight management.

Take Home Naloxone Program Expands in Australia

Take Home Naloxone Program Expands in Australia

Discover how free Naloxone nasal spray is saving lives by reversing opioid toxicity in emergencies and the THN program expanding access in Australia.

FDA Approves Obe-cel CAR T Therapy for Relapsed B-cell ALL

FDA Approves Obe-cel CAR T Therapy for Relapsed B-cell ALL

Explore the groundbreaking obe-cel CAR T cell therapy for relapsed B-cell ALL, showcasing high efficacy and FDA approval as a promising treatment option.

Advertisement